Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2029989 | 1.00 | SLC7A5 (0.33) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL2158686 | 0.88 | SLC1A1 (0.37) | SLC1A1 | |
| Serine SCHEMBL17603641 | 0.87 | SLC7A5 (0.45) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A | |
| Serine SCHEMBL8015844 | 0.86 | SLC7A5 (0.37) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL17423639 | 0.84 | SLC7A5 (0.32) | SLC7A5SLC1A1 | |
| Ethylene Glycol SCHEMBL15602746 | 0.83 | CHRNB2 (0.34) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL723257 | 0.83 | SLC7A5 (0.39) | SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL6757940 | 0.83 | SLC7A5 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL17222464 | 0.83 | SLC7A5 (0.36) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL2027762 | 0.83 | SLC7A5 (0.36) | SLC7A5GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024141786-A2 | MULTITARGET VACCINES AND THERAPEUTICS | POPVAX PRIVATE LIMITED (IN) | 2024-07-04 | — | — | WO | claimed |
| US-10745449-B2 | UspA2 protein constructs and uses thereof | GLAXOSMITHKLINE (BE) | 2020-08-18 | — | — | US | claimed |
| CN-111499701-A | USPA2 protein constructs and uses thereof | 葛兰素史密斯克莱生物公司 | 2020-08-07 | — | — | CN | claimed |
| EP-3110438-B1 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2019-01-02 | — | — | EP | claimed |
| US-20180354996-A1 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2018-12-13 | — | — | US | claimed |
| EP-3110438-A1 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | GlaxoSmithKline Biologicals SA (BE) | 2017-01-04 | — | — | EP | claimed |
| CN-106061995-A | Uspa2 protein constructs and uses thereof | 葛兰素史密斯克莱生物公司 | 2016-10-26 | — | — | CN | claimed |
| WO-2015125118-A1 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2015-08-27 | — | — | WO | claimed |
| WO-2024141784-A2 | BROADLY PROTECTIVE BETACORONAVIRUS VACCINES AND COMPOSITIONS | POPVAX PRIVATE LIMITED (IN) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141786-A2 | MULTITARGET VACCINES AND THERAPEUTICS | POPVAX PRIVATE LIMITED (IN) | 2024-07-04 | — | — | WO | disclosed |
| CN-111712517-B | IL-1 RAP-targeted CAR-T cells and their uses | 法国血液机构 | 2024-05-14 | — | — | CN | disclosed |
| CN-109922825-B | Vaccine for resisting porcine parvovirus and porcine reproductive and respiratory syndrome virus and preparation method thereof | 勃林格殷格翰动物保健有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-11730806-B2 | Methods of manufacturing an immunogenic composition comprising a recombinant protein | BOEHRINGER INGELHEIM VETMEDICA GMBH | 2023-08-22 | — | — | US | disclosed |
| EP-3534939-B1 | VACCINE AGAINST PORCINE PARVOVIRUS AND PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND METHODS OF PRODUCTION THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| EP-1032658-A1 | NOVEL PECTATE LYASES | NOVO NORDISK A/S (DK) | 2000-09-06 | — | — | EP | disclosed |
| EP-0950100-A1 | KERATINOCYTE GROWTH FACTOR-2 (KGF-2 OR FIBROBLAST GROWTH FACTOR-12, FGF-12) | HUMAN GENOME SCIENCES, INC. (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1999027084-A1 | NOVEL PECTATE LYASES | NOVO NORDISK A/S (DK) | 1999-06-03 | — | — | WO | disclosed |
| WO-1998006844-A1 | KERATINOCYTE GROWTH FACTOR-2 (KGF-2 OR FIBROBLAST GROWTH FACTOR-12, KGF-12) | HUMAN GENOME SCIENCES, INC. (US) | 1998-02-19 | — | — | WO | disclosed |
| WO-1991019505-A1 | MODIFIED HUMAN HEMOGLOBIN, BLOOD SUBSTITUTES CONTAINING THE SAME, AND VECTORS FOR EXPRESSING THE MODIFIED HEMOGLOBIN | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-12-26 | — | — | WO | disclosed |
| EP-0355460-A2 | Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization | AMERICAN CYANAMID COMPANY (US) | 1990-02-28 | — | — | EP | disclosed |